DEADLINE FOR WRITTEN COMMENTS: Feb 28, 2010

Regardless of attendance at the public hearing, interested persons may submit written or electronic comments to the Division of Dockets Management. Submit a single copy of electronic comments or two paper copies of any mailed comments, except that individuals may submit one paper copy. Comments should be identified with the docket number (see below). Received comments may be seen in the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday.

Submit written comments to:

Division of Dockets Management (HFA305)
Food and Drug Administration
5630 Fishers Lane, rm. 1061
Rockville, MD 20852.

Submit electronic comments to: http://www.regulations.gov

Docket no: FDA-2009-N-0441

BACK TO HOME PAGE

Created by Ignite Health | @skypen | copyright 2010
All logos on this site have been used with expressed permission of their respective owners.

This Web site has been created as a free service to the healthcare communications industry and its related stakeholders that are interested in following the news, blogs, and tweets regarding the FDA public hearings on the use of the Internet and Social Media for health-related communications. The feeds on this site are being pulled dynamically from a variety of publicly-available sources, and the content of the feeds do not necessarily represent the views of, and should not be attributed to, either the creator of this site or the companies and individuals whose logos appear on this site as a sign of support for this event.